Small wholesalers blast Zuellig Pharma Korea’s sales policy

Local small drug wholesalers attacked Zuellig Pharma Korea (ZPK) with fierce criticism after the company asked for 120 percent collateral from wholesalers who want to make a direct deal with ZPK.

To make matters worse, ZPK rejected to accept any notes issued by large hospitals, let alone medium-sized hospitals’ notes.

Under such circumstances, small wholesalers complained that they cannot...